How many drugs treat Herpes simplex keratitis?

Drug Landscape tracks 1 marketed treatments for Herpes simplex keratitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/herpes-simplex-keratitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Herpes simplex keratitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Herpes simplex keratitis (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Herpes simplex keratitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Dendrid	IDOXURIDINE	Novartis	Nucleoside Analog Antiviral	Thymidine kinase, cytosolic		1963-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Herpes simplex keratitis
Novartis · 1 drug in Herpes simplex keratitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Herpes simplex keratitis:

Cite this brief

Drug Landscape (2026). Herpes simplex keratitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/herpes-simplex-keratitis. Accessed 2026-06-10.

Herpes simplex keratitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing